Ruane, Cunniff & Goldfarb’s Bio-Techne TECH Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$237M	Sell	3,348,841 -43,160	-1%	-$2.33M	3.68%	13
2026 Q1	$177M	Buy	3,392,001 +1,926,066	+131%	+$116M	2.94%	16
2025 Q4	$86.2M	Sell	1,465,935 -7,820	-0.5%	-$475K	1.35%	19
2025 Q3	$82M	Buy	1,473,755 +1,321,338	+867%	+$70.8M	1.36%	18
2025 Q2	$7.84M	Buy	+152,417	New	+$7.66M	0.13%	22
2016 Q1	–	Sell	-10,160	Closed	-$229K	–	146
2015 Q4	$229K	Hold	10,160	–	–	﹤0.01%	141
2015 Q3	$235K	Hold	10,160	–	–	﹤0.01%	141
2015 Q2	$250K	Hold	10,160	–	–	﹤0.01%	136
2015 Q1	$255K	Hold	10,160	–	–	﹤0.01%	140
2014 Q4	$235K	Hold	10,160	–	–	﹤0.01%	142
2014 Q3	$238K	Hold	10,160	–	–	﹤0.01%	146
2014 Q2	$235K	Hold	10,160	–	–	﹤0.01%	141
2014 Q1	$217K	Hold	10,160	–	–	﹤0.01%	140
2013 Q4	$240K	Hold	10,160	–	–	﹤0.01%	139
2013 Q3	$203K	Buy	+10,160	New	+$193K	﹤0.01%	144

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's TECH Position: Q2 2026 in Review

Ruane, Cunniff & Goldfarb reduced its Bio-Techne (TECH) stake by 1.3% in Q2 2026, selling an estimated $2.33M and leaving 3,348,841 shares worth $237M. The position accounts for 3.68% of the portfolio, ranked #13.

Ruane, Cunniff & Goldfarb first reported a position in TECH in Q3 2013 and has held it in 15 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Ruane, Cunniff & Goldfarb held 3,348,841 shares of Bio-Techne worth $237M as of Q2 2026.
Ruane, Cunniff & Goldfarb sold 43,160 Bio-Techne shares in Q2 2026, an estimated $2.33M.
Bio-Techne made up 3.68% of Ruane, Cunniff & Goldfarb's portfolio in Q2 2026, its #13 holding.
Ruane, Cunniff & Goldfarb first reported a position in Bio-Techne in Q3 2013 and has held it in 15 quarters since.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q2 2026, filed 14 Aug 2026.